AbbVie Sues Sandoz Over Testosterone Gel Patents
An AbbVie Inc. subsidiary on Monday sued Novartis AG's Sandoz Inc. in Delaware federal court for allegedly infringing 11 of its patents regarding its testosterone gel, AndroGel....To view the full article, register now.
Already a subscriber? Click here to view full article